Business
Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical Innovations
Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, participated in the prestigious 2025 VBEF Future Healthcare and Medicine Conference hosted by VCBeat at the Suzhou International Expo Centre May 9-10th. Fangzhou's founder, chairman, and CEO Dr. Xie Fangmin was named "Most Influential Healthcare Entrepreneur" as part of the 2025 Annual Future Healthcare Awards. The recognition highlights Fangzhou's decade-long evolution as a pioneer in online medic
About this update from Fangzhou Inc.
[{"type":"text","content":"SUZHOU, China, May 13, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, participated in the prestigious 2025 VBEF Future Healthcare and Medicine Conference hosted by VCBeat at the Suzhou International Expo Centre May 9-10th. Fangzhou's founder, chairman, and CEO Dr. Xie Fangmin was named "Most Influential Healthcare Entrepreneur" as part of the 2025 Annual Future Healthcare Awards. The recognition highlights Fangzhou's decade-long evolution as a pioneer in online medical services, including its latest advancements in large language models and safeguards against AI hallucination risks.","length":705,"tagName":"p"},{"type":"image","alt":"Fangzhou Inc. (PRNewsfoto/Fangzhou Inc.)","displaySize":"","headline":null,"caption":"Fangzhou Inc. (PRNewsfoto/Fangzhou Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":127,"url":"https://media.zenfs.com/en/prnewswire.com/ec3b6ecc368092a3d079d531670f2342"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UzhMEweRObfFg12_yi_6IQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIyNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/ec3b6ecc368092a3d079d531670f2342","width":400,"height":127}},"href":"https://mma.prnewswire.com/media/2544392/Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Dr. Xie Fangmin commented, "I am privileged to accept this award, and this recognition underscores Fangzhou's commitment to developing innovative healthcare solutions that prioritize both safety and intelligence. Looking ahead, we remain dedicated to our mission of leveraging AI technologies to broaden healthcare accessibility, improve patient outcomes, and drive the next generation of intelligent healthcare services."","length":436,"tagName":"p"},{"type":"text","content":"Policy Alignment","length":16,"tagName":"p"},{"type":"text","content":"Fangzhou's growth strategy aligns with China's AI regulatory framework for healthcare, including the recent 2025-2030 Pharmaceutical Industry Digital Transformation Implementation Plan which emerged from a collaborative effort among seven regulatory bodies, comprising the Ministry of Industry and Information Technology ("MIIT"), the National Health Commission, the Ministry of...